source
- Veradermics reports positive Phase 3 results for oral baldness pillVeradermics said its experimental oral formulation of minoxidil met the primary goal of its Phase 3 trial, showing significantly more new hair growth over six months compared with placebo. The dru…
- New U.S. hepatitis B vaccine policy targeting only at-risk newborns could raise infant infections and costs, studies warnA new U.S. recommendation limits the birth‑dose hepatitis B vaccine to infants who are judged to be at risk of neonatal infection, rather than offering it universally to all newborns. One study co…